XML 78 R68.htm IDEA: XBRL DOCUMENT v3.24.3
Discontinued Operations and Disposal Groups - Schedule of Statement of Operations (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 28, 2024
Sep. 30, 2023
Sep. 28, 2024
Sep. 30, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Loss on deconsolidation $ 60,639 $ 60,639 $ 60,639 $ 60,639
Non-refundable payments 10,150 10,150 10,150 10,150
Disposed of by Sale        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Cash $ 1,356 $ 1,356 $ 1,356 1,356
Disposed of by Sale | Carti Heal        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Selling, general and administrative expense       1,728
Research and development expense       396
Change in fair value of contingent consideration       1,710
Depreciation and amortization       4,264
Operating loss from discontinued operations       (8,098)
Interest expense, net       4,889
Other (income) expense       61,442
Other expense       66,331
Loss before income taxes       (74,429)
Income tax benefit, net       0
Net loss from discontinued operations       (74,429)
Loss attributable to noncontrolling interest - discontinued operations       14,937
Net loss attributable to Bioventus Inc. - discontinued operations       $ (59,492)